In silico SCREENING OF Ziziphus spina-christi (L.) Desf. AND Strychnos ligustrine COMPOUNDS AS A PROTEASE INHIBITOR OF SARS-COV-2
DOI:
https://doi.org/10.18006/2021.9(Spl-2-ICOPMES_2020).S208.S214Keywords:
Molecular docking, Coronavirus, Ziziphus spina-christi, Strychnos ligustrine, Jubanine BAbstract
Diseases caused by the coronavirus have become an important concern in early 2020. The coronavirus is a new type of virus that is included in the SARS-CoV-2 group. One of the possible mechanisms of SARS-CoV-2 inhibition involves protease receptors inhibition. This research was aimed to in silico screening of Ziziphus spina-christi (L.) Desf., and Strychnos ligustrine active ingredients as the main protease inhibitors of SARS-CoV-2 by assessing the ligand-binding affinity in the binding pocket of SARS-CoV-2 main protease protein. The molecular docking method is generally used to predict the inhibitory site and bonds formation. In the current study, some generally used antiviral compounds from the PDB (Protein Data Bank) were also used to compare the affinity strength of the test compound against the protease receptor (code of 5R7Y). The inhibitory activity against the main protease receptor proven by the ChemPLP score is more negative than the receptor’s native ligand and the comparison compounds. Jubanine B, a compound of Z. spina-christi has the most robust inhibition activity on the SARS-CoV-2 protease receptor. Results of this study can be concluded that this can be used to develop as a candidate for traditional medicine against SARS-CoV-2 but still it required some more in vitro and in vivo studies.
References
Asgarpanah J, Haghighat E (2015) Phytochemistry and pharmacologic properties of Ziziphus Spina-Christi (L.) Willd. African Journal of Pharmacy and Pharmacology 6(31): 2332 - 2339.
Berry M, Fielding B, Gamieldien J (2015) Practical considerations in virtual screening and molecular docking. In: Tran QN, Arabnia H (Eds), Emerging trends in computational biology, bioinformatics, and systems biology. Elsevier Inc. https://doi.org/10.1016/B978-0-12-802508-6.00027-2.
Elfik AA (2020) Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sciences 248(5):6. https://doi.org/ 10.1016/j.lfs.2020.117477.
Fearo D, Powell AJ, Douangamath A, Owen CD, Wild C, Krojer T, Lukacik P, Strain-Damerell CM, Walsh MA, von Delft F (2020) PanDDA analysis group deposition-crystal structure of COVID-19 main protease in complex with Z45617795. https://doi.org/10.2210/pdb5R7Y/pdb
Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Methods in Molecular Biology 1282(1): 1 – 23. doi: 10.1007/978-1-4939-2438-7_1.
Food and Drug Monitoring Agency, Republic of Indonesia (2020) Covid-19 drug information in Indonesia, Jakarta, available at http://online.flipbuilder.com/tbog/infi/mobile/index.html Retrieved on April 22, 2021,
Gusmailina & Komarayati KS (2015) Potential exploration of snakewood (Strychnos lucida) organic compounds as a biopharmaceutical source. National Seminar Process of Indonesian Biodiversity Society 1(7):1741 – 1746.
Jualiana K, Amin M (2016) Development of textbooks for cell biology courses with bioinformatics approach for undergraduate students of Malang State University. Educational, Theory, Research and Development Journal 1(9):1677– 1683.
Kurniawan SN (2015) Neuronal signaling. Malang Neurology Journal 1(2):86–96.
Maulana M (2018) Thin layer chromatography (TLC) profile of arabiclote tree leaf extract (Ziziphus spina-christi L.) based on solvent variation (Mini Thesis). Malang: Faculty of Science and Technology, Maulana Malik Ibrahim Islamic State University, Pp.10-11.
Mauludiyah EN, Fitrianti D, Gita CED (2020) Phytochemical screening of secondary metabolite compounds from simplicia and water extract of arabic bidara (Ziziphus Spina-Christi L.) leaves. Seminar Penelitian Sivitas Akademika Unisba 6 (2):https://doi.org/10.29313/.V6i2.24325
Negash L (2019) Ziziphus spina-christi ( L.) Desf. (Rhamnaceae).In: A selection of Ethiopia’s indigenous trees: biology, uses, and propagation techniques, Addis Ababa University Press, Ethiopia, Pp. 334.
Niaz A (2020) Remdesivir & chloroquine can effectively inhibit the recently emerged novel coronavirus (2019-NCOV) in vitro. Cell Research 30 (1): 269-271. https://doi.org/10.1038/s41422-020-0282-0
Novian DR, Ikhwani AZN, Winarso A (2019) Tests of pharmacodynamic, drug-likeness, pharmacokinetic and interaction of snakewood (Strychnos lucida) active compound as in silico Plasmodium falciparum inhibitor. Archipelago Veterinary Journal 2(1):78.
Purnomo H (2013) Computational chemistry for pharmacy and science related to in silico test and anticancer compounds, 1st ed. Yogyakarta: Student Library, Pp.210.
Rale SD (2018) Antioxidant and in vitro activity of alpha-glucosidase inhibition of snakewood (Strychnos nitida G. Don) trunk ethanol extract and identification of active compounds. Thesis submitted to the Graduate School of Bogor Agricultural Institute h.1–2.
Rangwal H, Karypis G (2008) RMSD Pred: predicting local RMSD between structural fragments using sequence information. Proteins 72 : 1005-18.
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic treat for coronavirus disease 2019 (COVID-19). JAMA Network doi:10.1001/jama.2020.6019
Santos J, Brierley S, Gandhi MJ, Cohen MA, Moschella PC, Declan ABL (2020) Repurposing therapeutics for potential treatment of SARS-CoV-2: a review. Viruses 12 (7): 705; https://doi.org/10.3390/v12070705
Syahputra G, Ambarsari L, Sumaryada T (2014) Docking simulation of enol curcumin, bis-demethoxy curcumin and its analog as 12-lipoxygenase enzyme inhibitor. Biophysics Journal 10(1): 55 – 67.
Taek M, Tukan G (2018) Antimalarial activity of snakewood extract (Strychnos ligustrina) in mice infected with Plasmodium berghei. Natural Science Sains 1(3): 1 – 2.
Tegar M, Purnomo H (2013) Tea leaves extracted as anti-malaria based on molecular docking PLANTS. Procedia of Environmental Science 17: 188 - 94.
Trina TE, Sefren TG, Nurdjannah NJ, Fatimawali, Billy KJ, Idroes R, et al. (2020) Potential of plant bioactive compounds as SARS-Cov-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: a molecular docking study. Preprints 2(2):1–18.
Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R (2020) Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science 368 (6489):409-412. https://doi.org/ 10.1126/science.abb3405.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.